ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

April 20, 1990

Digital Immunoassay PSA Test May Predict Cancer Recurrence

October 28, 2011

Fruit, Candy Flavored Cigarettes Banned In U.S.; FDA To Examine Menthol Flavored Tobacco

September 25, 2009

$150 Mil. For Army Breast Cancer Program Urged In Letter

September 16, 1994

In Brief: Chabner Names DCT Acting Director, Schepartz Returns To Deputy Job; GM Winners Announced

July 3, 1981

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993